FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W976436556> ?p ?o ?g. }

• W976436556 abstract "There is no consensus on the optimal treatment for patients with advanced non-small-cell lung cancer (NSCLC) and stable disease (SD) after gefitinib therapy. This randomized, open-label, multicenter study aimed to explore whether dose-escalation of gefitinib would improve response and survival in NSCLC patients who achieved SD after one-month of standard gefitinib dosage. Between May 2009 and January 2012, 466 patients were enrolled and 100 eligible patients were randomized (1:1) to receive either a higher dose (500 mg/d; H group) or to continue standard dose (250 mg/d; S group) of gefitinib. Objective response rate (ORR) was similar between the two groups (12.5% vs 12.5%, p = 1.000). There were no significant differences regarding progression-free survival (PFS) and overall survival (OS) between both arms (H group vs S group: median PFS, 5.30 months vs 6.23 months, p = 0.167; median OS, 13.70 months vs 18.87 months, p = 0.156). Therefore, dose-escalation of gefitinib does not confer a response or survival advantage in patients who achieve SD with one month of standard-dose gefitinib treatment." @default.
• W976436556 created "2016-06-24" @default.
• W976436556 creator A5014963018 @default.
• W976436556 creator A5027373861 @default.
• W976436556 creator A5031810848 @default.
• W976436556 creator A5058691896 @default.
• W976436556 creator A5060519536 @default.
• W976436556 creator A5066716873 @default.
• W976436556 creator A5069860538 @default.
• W976436556 creator A5070121957 @default.
• W976436556 creator A5070605818 @default.
• W976436556 creator A5072795022 @default.
• W976436556 creator A5082267366 @default.
• W976436556 creator A5085159332 @default.
• W976436556 creator A5089851953 @default.
• W976436556 date "2015-07-28" @default.
• W976436556 modified "2023-09-23" @default.
• W976436556 title "Randomized, Multicenter Study of Gefitinib Dose-escalation in Advanced Non-small-cell Lung Cancer Patients Achieved Stable Disease after One-month Gefitinib Treatment" @default.
• W976436556 cites W137968785 @default.
• W976436556 cites W2018708014 @default.
• W976436556 cites W2037581548 @default.
• W976436556 cites W2040604770 @default.
• W976436556 cites W2045993433 @default.
• W976436556 cites W2047665602 @default.
• W976436556 cites W2075473083 @default.
• W976436556 cites W2080773827 @default.
• W976436556 cites W2113491100 @default.
• W976436556 cites W2120718661 @default.
• W976436556 cites W2130106644 @default.
• W976436556 cites W2139248078 @default.
• W976436556 cites W2140775102 @default.
• W976436556 cites W2146404049 @default.
• W976436556 cites W2154226624 @default.
• W976436556 cites W2161821474 @default.
• W976436556 cites W2165651085 @default.
• W976436556 cites W2166084034 @default.
• W976436556 cites W2169961966 @default.
• W976436556 cites W2219978888 @default.
• W976436556 doi "https://doi.org/10.1038/srep10648" @default.
• W976436556 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4516974" @default.
• W976436556 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26216071" @default.
• W976436556 hasPublicationYear "2015" @default.
• W976436556 type Work @default.
• W976436556 sameAs 976436556 @default.
• W976436556 citedByCount "8" @default.
• W976436556 countsByYear W9764365562016 @default.
• W976436556 countsByYear W9764365562017 @default.
• W976436556 countsByYear W9764365562018 @default.
• W976436556 countsByYear W9764365562019 @default.
• W976436556 countsByYear W9764365562020 @default.
• W976436556 countsByYear W9764365562021 @default.
• W976436556 crossrefType "journal-article" @default.
• W976436556 hasAuthorship W976436556A5014963018 @default.
• W976436556 hasAuthorship W976436556A5027373861 @default.
• W976436556 hasAuthorship W976436556A5031810848 @default.
• W976436556 hasAuthorship W976436556A5058691896 @default.
• W976436556 hasAuthorship W976436556A5060519536 @default.
• W976436556 hasAuthorship W976436556A5066716873 @default.
• W976436556 hasAuthorship W976436556A5069860538 @default.
• W976436556 hasAuthorship W976436556A5070121957 @default.
• W976436556 hasAuthorship W976436556A5070605818 @default.
• W976436556 hasAuthorship W976436556A5072795022 @default.
• W976436556 hasAuthorship W976436556A5082267366 @default.
• W976436556 hasAuthorship W976436556A5085159332 @default.
• W976436556 hasAuthorship W976436556A5089851953 @default.
• W976436556 hasBestOaLocation W9764365561 @default.
• W976436556 hasConcept C121608353 @default.
• W976436556 hasConcept C126322002 @default.
• W976436556 hasConcept C143998085 @default.
• W976436556 hasConcept C168563851 @default.
• W976436556 hasConcept C2775965419 @default.
• W976436556 hasConcept C2776256026 @default.
• W976436556 hasConcept C2779438470 @default.
• W976436556 hasConcept C2780580887 @default.
• W976436556 hasConcept C2992435398 @default.
• W976436556 hasConcept C71924100 @default.
• W976436556 hasConceptScore W976436556C121608353 @default.
• W976436556 hasConceptScore W976436556C126322002 @default.
• W976436556 hasConceptScore W976436556C143998085 @default.
• W976436556 hasConceptScore W976436556C168563851 @default.
• W976436556 hasConceptScore W976436556C2775965419 @default.
• W976436556 hasConceptScore W976436556C2776256026 @default.
• W976436556 hasConceptScore W976436556C2779438470 @default.
• W976436556 hasConceptScore W976436556C2780580887 @default.
• W976436556 hasConceptScore W976436556C2992435398 @default.
• W976436556 hasConceptScore W976436556C71924100 @default.
• W976436556 hasIssue "1" @default.
• W976436556 hasLocation W9764365561 @default.
• W976436556 hasLocation W9764365562 @default.
• W976436556 hasLocation W9764365563 @default.
• W976436556 hasLocation W9764365564 @default.
• W976436556 hasOpenAccess W976436556 @default.
• W976436556 hasPrimaryLocation W9764365561 @default.
• W976436556 hasRelatedWork W2027737109 @default.
• W976436556 hasRelatedWork W2050376166 @default.
• W976436556 hasRelatedWork W2069129404 @default.
• W976436556 hasRelatedWork W2083060521 @default.
• W976436556 hasRelatedWork W2210001221 @default.
• W976436556 hasRelatedWork W2336397012 @default.
• W976436556 hasRelatedWork W2345394748 @default.

• next